Advanced search
Publication Cover
Acta Orthopaedica Volume 81, 2010 - Issue 2
Journal homepage
1,933
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Single-dose versus multiple-dose antibiotic prophylaxis for the surgical treatment of closed fractures

A cost-effectiveness analysis

Gerard P Slobogean Department of Orthopaedics, University of British Columbia, Vancouver, BC
,
Peter J O'Brien Department of Orthopaedics, University of British Columbia, Vancouver, BC
&
Carmen A Brauer Department of Pediatric Orthopaedics, Alberta Children's Hospital, Calgary, Alberta, CanadaCorrespondence[email protected]
Pages 256-262 | Received 06 Apr 2009, Accepted 01 Oct 2009, Published online: 29 Jun 2010

  • Ali M, Raza A. Role of single dose antibiotic prophylaxis in clean orthopedic surgery. J Coll Physicians Surg Pak 2006; 16:45-8.
  • Anand A, Bashey B, Mir T, Glatt AE. Epidemiology clinical manifestations and outcome of Clostridium difficile-associated diarrhea. Am J Gastroent 1994; 89:519-23.
  • Bell CM, Chapman RH, Stone PW, Sandberg EA, Neumann PJ. An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses. Med Decis Making 2001; 21:288-94.
  • Bhandari M, Sprague S, Ayeni OR, Hanson BP, Moro JK. A prospective cost analysis following operative treatment of unstable ankle fractures: 30 patients followed for 1 year. Acta Orthop Scand 2004; 1:100-5.
  • Boyd RJ, Burke JF, Colton T. A double-blind clinical trial of prophylactic antibiotics in hip fractures. J Bone Joint Surg (Am) 1973; 55:1251-8.
  • Brauer CA, Waters PM. An economic analysis of the timing of microsurgical reconstruction in brachial plexus birth palsy. J Bone Joint Surg (Am) 2007; 89:970-8.
  • Buckley R, Hughes GNF, Snodgrass T, Perioperative cefazolin prophylaxis in hip fracture surgery. Can J Surg 1990; 33:122-5.
  • Burnett JW, Gustilo RB, Williams DN, Kind AC Prophylactic antibiotics in hip fractures. A double-blind, prospective study. J Bone Joint Surg (Am); 62: 457-62.
  • Dijksman LM, Poolman RW, Bhandari M, Goeree R, Tarride JE, International Evidence-Based Orthopaedic Surgery Working Group. Money matters: what to look for in an economic analysis. Acta Orthop. 2008; 79:1-11.
  • Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985; 5:157-77.
  • Garotta F, Pamparana F. Antimicrobial prophylaxis with ceftizoxime versus cefuroxime in orthopedic surgery. ceftizoxime orthopedic surgery italian study group. J Chemother 1991; 3:34-5.
  • Garrelts JC, Horst WD, Silkey B, Gagnon S. A pharmacoeconomic model to evaluate antibiotic costs. Pharmacotherapy 1994; 14:438-45.
  • Gatell JM, Riba J, Lozano ML, Mana J, Ramon R, Garcia SanMiguel J. Prophylactic cefamandole in orthopaedic surgery. J Bone Joint Surg (Am) 1984; 66:1219-22.
  • Gatell JM, Garcia S, Lozano L, Soriano E, Ramon R, SanMiguel JG. Perioperative cefamandole prophylaxis against infections. J Chemother 1987; 69:1189-93.
  • Gillespie WJ, Walenkamp G Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev 2006; 4.
  • Kuntz KM, Snider RK, Weinstein JN, Pope MH, Katz JN. Cost-effectiveness of fusion with and without instrumentation for patients with degenerative spondylolisthesis and spinal stenosis. Spine 2000; 25:1132-9.
  • Kyne L, Hamel B, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34:346-53.
  • O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007; 28:1219-27.
  • Pepin J, Valiquette L, Cossettee B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173:1037-42.
  • Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role off cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. JAMA 1996; 276:1172-7.
  • Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine. JAMA 1996; 276:1339-41.
  • Slobogean GP, Kennedy SA, Davidson D, O'Brien PJ. Single versus multiple dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma 2008; 22:264-9.
  • Southwell-Keely JP, Russo RR, March L, Cumming R, Cameron I, Brnabic AJ. Antibiotic prophylaxis in hip fracture surgery: A metaanalysis. Clin Orthop 2004; ((419):179-84.
  • Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis 1987; 40:593-603.
  • Walker D, Fox-Rushby J. Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis. Health Policy Plan 2001; 16:435-43.
  • Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996; 276:1253-8.
  • Zoutman D, McDonald S, Vethanayagan D. Total and attributal costs of surgical wound infections at a Canadian tertiary-care center. Infect Control Hosp Epidemiol 1998; 19:254-9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.